Jonathan Milner Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 66

  • Portfolio
  • 36

  • Exits
  • 10

Exits

Jonathan Milner General Information

Description

Dr. Jonathan Milner is a Co-Founder and serves as Chairman at Axol Biosciences. He serves as Board Member at PhoreMost, Nuclera and GeoSpock. He serves as Advisor at Bactobio. He also serves as a Member of the Advisory Panel at Cambridge Innovation Capital. He is a co-founder of Abcam and is an experienced entrepreneur and investor and is passionate about supporting UK healthcare and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three technology companies to IPO on AIM. He gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath University. From 1992-95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the laboratory of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Kouzarides. He is currently Chairman of Axol Bioscience, Camallergy Limited, and Definigen Limited. He serves as non-executive director of Horizon Discovery, Syndicate Room Limited, Repositive Limited, Elpis Biomedical Limited, Shift Biosciences Limited, HealX Limited. He was on the advisory board of Desktop Genetics Ltd. He serves as Board Member at LIfT BioSciences.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • Cambridge
  • England, United Kingdom

Jonathan Milner Investments (66)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Relation 19-Jan-2024 Seed Round 000.00 Drug Discovery Generating Revenue 00000000 000000 00.0
Pencil Biosciences 01-Oct-2023 0000 00000 Biotechnology Generating Revenue 00000000 000000 00.0
PharmEnable Therapeutics 22-May-2023 00000 00000 00.00 Drug Discovery Generating Revenue 00000000 000000 00.0
SolasCure 27-Mar-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 00000000 000000 00.0
NanoSyrinx 10-Nov-2022 0000 00000 00.000 Drug Delivery Generating Revenue 00000000 000000 00.0
Nuclera 06-Jul-2022 00000 00000 000.00 Biotechnology Generating Revenue 00000000 000000 00.0
Spirea 14-Jun-2022 00000 00000 00.000 Drug Discovery Generating Revenue 00000000 000000 00.0
CoSyne Therapeutics 20-May-2022 00000 00000 00.000 Drug Discovery Startup 00000000 000000 00.0
Axol (Biotechnology) 07-Apr-2022 Later Stage VC 00.00 Biotechnology Generating Revenue 00000000 000000 00.0
Afferent Medical Solutions 25-Mar-2022 Seed Round 00000 Other Devices and Supplies Clinical Trials - Phase 2 00000000 000000 00.0

Jonathan Milner Exits (10)

Company Name Exit Date Exit Type Exit Size
SyndicateRoom 01-Oct-2023 Secondary Transaction - Private
GeoSpock 14-Jun-2023 0000000000: 000000
Valence Labs 16-May-2023 000000000000000000 000.00
Sense Biodetection 01-Feb-2023 000000000000000000
Sensiia 01-Nov-2022 0000000000: 000000
Repositive 12-Nov-2021 0000000000: 000000
Genomes Unzipped 01-Jun-2018 000000000000000000
GeneAdviser 21-Jun-2017 000 00 00000000
Oval Medical Technologies 13-Dec-2016 Merger/Acquisition
Horizon Discovery 27-Mar-2014 IPO 00000

Jonathan Milner Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Jonathan Milner Team (1)

Name Title Deals Funds Boards Office
Jonathan Milner Ph.D Angel Investor 00 0 Cambridge, United Kingdom

Jonathan Milner Co-Investors (115)

Name With Exits Lead Partner Series Industry
Meltwind Advisory 14 0 0 Series chart Industry bar
O2h Ventures 0 0 Series chart Industry bar
Parkwalk Advisors 0 0 Series chart Industry bar
SyndicateRoom 0 0 Series chart Industry bar
UK Innovation & Science Seed Fund 0 0 Series chart Industry bar

Jonathan Milner FAQs

  • Who is Jonathan Milner?

    Jonathan Milner is an angel Investor who has made 66 investments.

  • What kind of investor is Jonathan Milner?

    Jonathan Milner is an angel investor.

  • What does Jonathan Milner do?

    As an angel investor, Jonathan Milner invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Jonathan Milner hold?

    Jonathan Milner holds 3 board seats including LIfT BioSciences, Camallergy, and PhoreMost.

  • What has Jonathan Milner invested in?

    Jonathan Milner has made numerous investments in companies like Relation, Pencil Biosciences, and PharmEnable Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has Jonathan Milner invested in recently?

    Jonathan Milner's latest investment was on 19-Jan-2024 in Relation, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »